Literature DB >> 16524545

Whipple's Disease.

Klaus Mönkemüller1, Lucía C Fry, Steffen Rickes, Peter Malfertheiner.   

Abstract

Whipple's disease (WD) is a chronic debilitating disease caused by the bacillus Tropheryma whippleii. WD classically presents with the main clinical symptoms of polyarthralgias, chronic diarrhea, weight loss, and abdominal pain. Given its systemic involvement, it is common for WD to present with a multitude of other clinical scenarios--sometimes with predominant neurologic, cardiac, and dermatologic manifestations. WD can occur at any age, but it generally occurs during the fifth decade and predominantly in men. The diagnosis of WD is established by demonstrating the organism on biopsies from the involved system, by histology, electron microscopy, polymerase chain reaction, and more recently, by culture of bacteria. The histologic features include a coarse granular cytoplasm and foamy macrophages that stain strongly with the period-acid Schiff reagent. Current therapy includes an initial 2-week course of intravenous cephalosporins followed by 1-year oral trimethoprim-sulfamethoxazole.

Entities:  

Year:  2006        PMID: 16524545     DOI: 10.1007/s11908-006-0004-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

1.  Diagnosis and follow-up of Whipple's disease by amplification of the 16S rRNA gene of Tropheryma whippelii.

Authors:  B Pron; C Poyart; E Abachin; T Fest; C Belanger; C Bonnet; P Capelle; J F Bretagne; A Fabianek; L Girard; H Hagège; P Berche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

Review 2.  Whipple's disease.

Authors:  Florence Fenollar; Didier Raoult
Journal:  Curr Gastroenterol Rep       Date:  2003-10

3.  Treatment of refractory Whipple disease with interferon-gamma.

Authors:  T Schneider; A Stallmach; A von Herbay; T Marth; W Strober; M Zeitz
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

4.  Invasion and destruction of mucosal plasma cells by Tropheryma whippelii.

Authors:  M Eck; H Kreipe; D Harmsen; H K Müller-Hermelink
Journal:  Hum Pathol       Date:  1997-12       Impact factor: 3.466

5.  HLA B27 and defects in the T-cell system in Whipple's disease.

Authors:  G E Feurle; B Dörken; E Schöpf; V Lenhard
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

6.  Treatment of Whipple's disease with sulphamethoxazole-trimethoprim.

Authors:  L Elsborg; E Gravgaard; N O Jacobsen
Journal:  Acta Med Scand       Date:  1975 Jul-Aug

Review 7.  Whipple's disease confined to the central nervous system: case report and review of the literature.

Authors:  T Süzer; N Demirkan; K Tahta; E Coskun; B Cetin
Journal:  Scand J Infect Dis       Date:  1999

Review 8.  Whipple's disease.

Authors:  Julio C Bai; Roberto M Mazure; Horacio Vazquez; Sonia I Niveloni; Edgardo Smecuol; Silvia Pedreira; Eduardo Mauriño
Journal:  Clin Gastroenterol Hepatol       Date:  2004-10       Impact factor: 11.382

9.  Whipple's disease with aortic regurgitation requiring aortic valve replacement.

Authors:  T Schneider; M Salamon-Looijen; A von Herbay; H Schwerdt; S Weg-Remers; A Stallmach; M Zeitz
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

10.  Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease.

Authors:  M A Schwartz; J B Selhorst; A L Ochs; R W Beck; W W Campbell; J K Harris; B Waters; M E Velasco
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

View more
  1 in total

Review 1.  Whipple's Disease.

Authors:  Wilfried Obst; Ulrike von Arnim; Peter Malfertheiner
Journal:  Viszeralmedizin       Date:  2014-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.